Clarus Wealth Advisors Global Blood Therapeutics, Inc. Transaction History

Clarus Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 11, 2019	SELL	$45.35 - $57.91 $21,586 - $27,565	-476 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$31.54 - $46.67 $7,506 - $11,107	238 Added 100.0%	476 $20,000
Q4 2018 Jan 08, 2019	BUY	$31.54 - $46.67 $7,506 - $11,107	238 New	238 $9,000
Q4 2018 Jan 07, 2019	SELL	$31.54 - $46.67 $7,506 - $11,107	-238 Closed	0 $0
Q3 2018 Oct 03, 2018	BUY	$38.0 - $51.1 $9,044 - $12,161	238 New	238 $9,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Clarus Wealth Advisors with notifications on news.